ai
we ee
Subject
No.
Age
and Sex
WBC
(«x1O°)
Neut.
(10°)
Hematological Findings, 1939
Lymph.
CxO)
Eosin.
C10)
Baso.
€«1O%:
Mono.
(x10%)
Plate.
(x10)
RBC
x10)
“o Retic.
Heb.,g
MCH, ¢
(«10°85
3M
3F
+ MP
5M
4F
3M
4F
5F
5F
5M
7M
8M
OF
8M
10 M
10M
10F
13M
15 M
17 F
22F
13.9
13.5
LLL
20.2
12.7
11.8
9.0
12.6
14.7
10.6
tL.
8.7
11.8
12.3
6.4
12.2
9.
9.6
10.4
10.8
10.5
8.5
7.9
4.3
11.3
6.6
5.1
3.5
6.8
4.6
$1
6.3
4.2
5.2
7.6
2.5
5.6
2.5
4.1
5.7
6.0
7.4
3.0
4.8
5.4
7.3
3.0
5.3
4.9
4.3
6.2
5.8
4.4
3.7
3.7
3.7
3.7
4.0
6.0
4.9
+.
4.6
2.6
828
829
830
831
832
833
834
835
836
838
839
840
19M
20 F
20M
19 M
21F
26 M
25M
25F
26 M
27M
31 F
29M
11.5
7.3
7.4
8.0
10.8
7.9
10.1
10.1
9.5
10.2
11.7
9.6
2.3
4.7
3.6
3.6
7.7
3.2
5.9
5.7
4.9
3.4
7.3
3.9
9.0
2.6
3.2
3.4
2.6
4.0
27
3.2
4.5
6.0
3.9
4.7
0.1
0
0.4
0.7
0.3
0.3
1.0
0.7
0.2
0.2
0.2
0.3
842
843
844
845
846
849
850
B51
852
853
854
855
856
858
859
860
B61
862
863
864
35M
30 F
40 F
29M
36 F
40 M
48 M
50 F
55 F
54 M
54 F
54M
60M
64 F
66 F
69 M
69 F
85 M
9M
33M
5.9
6.8
5.7
3.3
8.5
49
7.3
4.6
4.9
3.4
6.8
5.5
3.5
3.6
4.4
3.5
4.7
4.0
4.0
4.6
4.0
2.7
3.5
4.4
2.9
6.0
44
3.5
5.3
3.9
2.9
24
27
3.0
4.5
4.1
3.1
3.5
5.3
4.5
0.1
0.6
0.1
0.5
0.6
0.7
0
O04
0.5
0.5
0.3
0.5
0.3
0.
0.3
0.3
0.2
0.6
0.7
0.7
827
eRAe A RePenden oe
Ou
19M
26 F
4.5
11.2
10.6
10.2
9.7
8.4
124
11.9
11.8
8.8
10.9
7.6
10.1
8.9
6.8
6.6
9.3
8.5
83
8.0
10.3
9.7
2.5
6.2
1.6
3.6
0.1
2.8
0.8
1.0
0.9
1.2
0.3
1.3
3.1
0.7
0.15
0.7
0.6
0.6
0.6
2.3
0.2
0.5
0.6
0
0.3
0.2
0
0
0
0.2
0
Q
0
01
0.2
0
0.05
0.05
Ou
0
0
0.1
0
0
0
0
0
0
0.3
0
0.3
0.6
0.3
0.2
0.8
0.05
0.9
0.2
0.05
0.1
0.1
0.15
0.1
0.2
0.3
0.05
0
0.1
0.1
139.0
397.0
450.0
—
535.0
600.0
340.0
412.0
295.0
395.0
350.0
205.0
358.0
575.0
195.0
412.0
255.0
220.0
272.0
410.0
—
4.61
5.52
4.55
3.64
4.84
3.95
4.44
4.11
4.33
4.45
4.25
4.05
4.24
4.79
4.11
4.63
4.47
4.55
$51
4.76
4.10
0.1
0.8
0.2
0
0.1
0
0.6
0.4
0
0
0
0.2
0.1
0.4
0.6
0
0.1
0
0
0.5
0
13.6
12.0
11.8
10.0
13.2
123
12.9
11.9
12.7
12.0
13.0
11.4
Lit
13.2
12.1
12.4
11.9
14.8
12.5
13.2
10.0
39.5
21.5
26.0
27.5
27.9
31.5
27.5
29.0
28.0
27.0
30.5
28.0
27.0
27.5
29.5
27.0
26.4.
32.5
27.5
27.5
24.5
0.1
0
0
0.1
0
0.1
0
0.1
0
0
0
0.05
0
0
0.1
0.4
0.15
0
0.4
0.3
0
0.5
0.2
0.5
289.0
205.0
283.0
252.0
270.0
325.0
303.0
337.0
280.0
225.0
392.0
253.0
3.10
4.00
4.93
5.10
4.03
5.61
5.06
4.29
5.40
4.75
4.24
5.76
0.2
0
0.2
0.3
0.2
0.8
0.1
0
0.1
0.2
0.6
1.4
15.8
11.9
15.8
16.8
10.8
15.4
14.8
13.6
16,2
16.8
11.7
15.2
31.0
30.0
32.0
33.0
27.0
27.5
29.0
31.5
30.0
35.5
27.5
26.5
0.3
O.1
0
0.1
0
0.1
0
. O1
“0
Oa
0
0.1:
o.1*
0
0
0.2
0
0
0
0.1
0.3
0.05
0.3
0.2
0.1
0.3
0.1
0.2
0.3
0.4
0.1
0.4
0.2
0
0.2
0.4
0.4
0
0
0.2
272.0
280.0
250.0
257.0
265.0
310.0
255.0
280.0
278.0
205.0
372.0
230.0
255.0
295.0
395.0
262.0
205.0
260.0
345.0
170.0
5.47
3.60
4.51
5.00
3.78
5.42
4.87
4.07
4.38
4.73
£.73
4.25
4.48
4.30
4.12
3.89
4.41
4.32
4.88
5.05
0.5
0.2
0.5
Q
0
1.0
0
0.2
0.2
0
0.1
0
0.4
0.8
0.2
0.1
0
1.0
0.6
0.6
18.2
11.9
12.5
14.1
11.6
16.8
15.4
13.1
12.1
15.2
13.6
14.2
13.8
12.9
12.6
11.9
13.0
14.2
13.7
16.0
33.0
33.0
28.0
28.0
30.5
31.0
31.5
32.0
97.5
32.0
29.0
33.5
31.0
30.0
30.5
30.5
99.5
33.0
27.0
31.0
0.04
0.1
0.1
05
—
230.0
4.55
4.40
0
0
12.5
12.6
97.5
98.5
—
803
804
806
807
808
809
B10
B11
812
B13
814
815
B16
818
819
820
821
822
823
825
826
se
Rongelap Control Population {continued}